
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SerpinB6 CRISPR/Cas9 KO Plasmid (h) | sc-417434 | 20 µg | $397.00 |
SERPINB6 encodes SerpinB6, an intracellular clade B serine protease inhibitor that contributes to cytoprotection by neutralizing aberrant protease activity and limiting proteolysis-driven cellular damage. By constraining serine proteases within the cytosol and nucleus, SerpinB6 supports proteostasis and stress-response processes that influence cell survival, differentiation, and inflammatory signaling. SERPINB6 expression is particularly relevant in epithelial and immune contexts where protease–antiprotease balance shapes barrier function and tissue homeostasis. Dysregulated serpin activity has been associated with altered susceptibility to proteotoxic stress and inflammatory pathology, making SERPINB6 a useful target for mechanistic studies of intracellular protease control.
SerpinB6 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SERPINB6 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SERPINB6 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SERPINB6 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SerpinB6 protein expression.
This CRISPR knockout system enables efficient generation of SERPINB6-deficient cell models for investigation of SerpinB6 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.